BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23887380)

  • 1. Development of vascular smooth muscle contractility by endothelium-derived transforming growth factor β proteins.
    Kimura C; Konishi S; Hasegawa M; Oike M
    Pflugers Arch; 2014 Feb; 466(2):369-80. PubMed ID: 23887380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained contraction and loss of NO production in TGFbeta1-treated endothelial cells.
    Watanabe M; Oike M; Ohta Y; Nawata H; Ito Y
    Br J Pharmacol; 2006 Oct; 149(4):355-64. PubMed ID: 16967050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-dependent epithelial-mesenchymal transition of tumor cells: exclusive roles of transforming growth factor β1 and β2.
    Kimura C; Hayashi M; Mizuno Y; Oike M
    Biochim Biophys Acta; 2013 Oct; 1830(10):4470-81. PubMed ID: 23668958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive nitric oxide production in bovine aortic and brain microvascular endothelial cells: a comparative study.
    Kimura C; Oike M; Ohnaka K; Nose Y; Ito Y
    J Physiol; 2004 Feb; 554(Pt 3):721-30. PubMed ID: 14617679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro.
    Merwin JR; Newman W; Beall LD; Tucker A; Madri J
    Am J Pathol; 1991 Jan; 138(1):37-51. PubMed ID: 1846264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with TGFbeta1 impairs mechanotransduction in bovine aortic endothelial cells.
    Watanabe M; Oike M; Ohta Y; Ito Y
    Br J Pharmacol; 2007 Feb; 150(4):424-33. PubMed ID: 17220908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor-beta 1.
    Sakuda H; Nakashima Y; Kuriyama S; Sueishi K
    Am J Pathol; 1992 Dec; 141(6):1507-16. PubMed ID: 1281623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells.
    Sharma K; Deelman L; Madesh M; Kurz B; Ciccone E; Siva S; Hu T; Zhu Y; Wang L; Henning R; Ma X; Hajnoczky G
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1258-70. PubMed ID: 12876066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic strain-induced endothelial MMP-2: role in vascular smooth muscle cell migration.
    von Offenberg Sweeney N; Cummins PM; Birney YA; Redmond EM; Cahill PA
    Biochem Biophys Res Commun; 2004 Jul; 320(2):325-33. PubMed ID: 15219830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells.
    Ishisaki A; Hayashi H; Li AJ; Imamura T
    J Biol Chem; 2003 Jan; 278(2):1303-9. PubMed ID: 12417591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of vascular cell behavior by transforming growth factors beta.
    Madri JA; Bell L; Merwin JR
    Mol Reprod Dev; 1992 Jun; 32(2):121-6. PubMed ID: 1637550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide anion impairs contractility in cultured aortic smooth muscle cells.
    Kimura C; Cheng W; Hisadome K; Wang YP; Koyama T; Karashima Y; Oike M; Ito Y
    Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H382-90. PubMed ID: 12063312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinol influences contractile function and exerts an anti-proliferative effect on vascular smooth muscle cells through an endothelium-dependent mechanism.
    Wang S; Wright G; Geng W; Wright GL
    Pflugers Arch; 1997 Nov; 434(6):669-77. PubMed ID: 9305997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of endothelium on cultured vascular smooth muscle cell proliferation.
    Peiró C; Redondo J; Rodríguez-Martínez MA; Angulo J; Marín J; Sánchez-Ferrer CF
    Hypertension; 1995 Apr; 25(4 Pt 2):748-51. PubMed ID: 7721427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of L-arginine transport and nitric oxide production by vascular smooth muscle and endothelium.
    Durante W; Liao L; Iftikhar I; O'Brien WE; Schafer AI
    Circ Res; 1996 Jun; 78(6):1075-82. PubMed ID: 8635238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell-conditioned medium downregulates smooth muscle contractile protein expression.
    Vernon SM; Campos MJ; Haystead T; Thompson MM; DiCorleto PE; Owens GK
    Am J Physiol; 1997 Feb; 272(2 Pt 1):C582-91. PubMed ID: 9124302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta as a differentiating factor for cultured smooth muscle cells.
    Gawaziuk JP; X ; Sheikh F; Cheng ZQ; Cattini PA; Stephens NL
    Eur Respir J; 2007 Oct; 30(4):643-52. PubMed ID: 17596270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular cell responses to TGF-beta 3 mimic those of TGF-beta 1 in vitro.
    Merwin JR; Roberts A; Kondaiah P; Tucker A; Madri J
    Growth Factors; 1991; 5(2):149-58. PubMed ID: 1768438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth.
    Dodge AB; Lu X; D'Amore PA
    J Cell Biochem; 1993 Sep; 53(1):21-31. PubMed ID: 8227180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells.
    Pollman MJ; Naumovski L; Gibbons GH
    Circulation; 1999 Apr; 99(15):2019-26. PubMed ID: 10209007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.